Eiken Chemical Co., Ltd.

Tokyo Stock Exchange 4549.T

Eiken Chemical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD -44.23 M

Eiken Chemical Co., Ltd. Net Cash Used Provided By Financing Activities is USD -44.23 M for the year ending March 31, 2024, a -180.47% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Eiken Chemical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD -15.77 M, a -259.96% change year over year.
Eiken Chemical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 9.86 M, a 185.62% change year over year.
Eiken Chemical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD -11.51 M, a -1.49% change year over year.
Eiken Chemical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD -11.34 M, a -16.15% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Tokyo Stock Exchange: 4549.T

Eiken Chemical Co., Ltd.

CEO	Mr. Tsugunori Notomi
IPO Date	Jan. 4, 2001
Location	Japan
Headquarters	4-19-9 Taito
Employees	757
Sector	Health Care
Industries Medical Instruments Biotechnology Chemicals & Advanced Materials Pharmaceuticals

Description

Eiken Chemical Co., Ltd. manufactures and sells clinical diagnostics and equipment in Japan. The company is involved in developing clinical diagnostic aids to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers. It also develops and supplies OC-SENSOR, an automated immunochemical fecal test for detecting gastrointestinal bleeding associated with disorders, such as colorectal cancer, polyps, and diverticulitis. In addition, the company offers real-time turbidi meters, and homeothermal equipment; amplification kits and fluorescence detection reagents for research use; and detection kits. Further, it manufactures a range of products that are used in the field of microbiology; and provides other products comprising immunological and serological reagents. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was founded in 1939 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years